Science

Marine molecule may help combat 'brain-eating' amoeba

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 27/10/2026, 14:55:25 UTC.

Briefings

A new study suggests a marine molecule could help treat primary amoebic meningoencephalitis (PAM), a deadly parasitic infection caused by Naegleria fowleri. The disease kills over 97% of infected patients within days, making it one of the most lethal infections known. This research aims to provide a potential cure for a condition with no effective treatment options.

Key points

• Primary amoebic meningoencephalitis (PAM) is a parasitic disease caused by the free-living amoeba Naegleria fowleri, with a fatality rate exceeding 97%.

Context

PAM is a lethal infection where the parasite causes rapid brain tissue deterioration, often leaving patients with only a few days to respond to treatment. This research represents a potential breakthrough for a condition with no effective treatment options.

Limitations

The evidence is limited to a single source article from October 2026. The study's findings are preliminary and may not be fully validated. No specific dates, locations, or named researchers are provided in the source material.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 27/10/2026, 14:57:31 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiamjrcln3ktvf2ty6lxlvx6moobhcfcishwcbqidrb5f62csmk4du